559 related articles for article (PubMed ID: 29421703)
1. Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents.
Nikookar H; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Ranjbar PR; Mahdavi M; Larijani B
Bioorg Chem; 2018 Apr; 77():280-286. PubMed ID: 29421703
[TBL] [Abstract][Full Text] [Related]
2. Pyrano[3,2-c]quinoline Derivatives as New Class of α-glucosidase Inhibitors to Treat Type 2 Diabetes: Synthesis, in vitro Biological Evaluation and Kinetic Study.
Heydari Z; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Mahdavi M; Ranjbar PR; Larijani B
Med Chem; 2019; 15(1):8-16. PubMed ID: 29807519
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
[TBL] [Abstract][Full Text] [Related]
4. Dihydropyrano [2,3-c] pyrazole: Novel in vitro inhibitors of yeast α-glucosidase.
Kashtoh H; Muhammad MT; Khan JJ; Rasheed S; Khan A; Perveen S; Javaid K; Atia-Tul-Wahab ; Khan KM; Choudhary MI
Bioorg Chem; 2016 Apr; 65():61-72. PubMed ID: 26874344
[TBL] [Abstract][Full Text] [Related]
5. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH
Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191
[TBL] [Abstract][Full Text] [Related]
6. Design, semisynthesis, α-glucosidase inhibitory, cytotoxic, and antibacterial activities of p-terphenyl derivatives.
Zhang XQ; Mou XF; Mao N; Hao JJ; Liu M; Zheng JY; Wang CY; Gu YC; Shao CL
Eur J Med Chem; 2018 Feb; 146():232-244. PubMed ID: 29407953
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.
Mohammadi-Khanaposhtani M; Rezaei S; Khalifeh R; Imanparast S; Faramarzi MA; Bahadorikhalili S; Safavi M; Bandarian F; Nasli Esfahani E; Mahdavi M; Larijani B
Bioorg Chem; 2018 Oct; 80():288-295. PubMed ID: 29980114
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of new fused carbazole-imidazole derivatives as anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and in silico studies.
Adib M; Peytam F; Shourgeshty R; Mohammadi-Khanaposhtani M; Jahani M; Imanparast S; Faramarzi MA; Larijani B; Moghadamnia AA; Esfahani EN; Bandarian F; Mahdavi M
Bioorg Med Chem Lett; 2019 Mar; 29(5):713-718. PubMed ID: 30661823
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion.
Ye GJ; Lan T; Huang ZX; Cheng XN; Cai CY; Ding SM; Xie ML; Wang B
Eur J Med Chem; 2019 Sep; 177():362-373. PubMed ID: 31158750
[TBL] [Abstract][Full Text] [Related]
10. Tyramine Derivatives as Potent Therapeutics for Type 2 Diabetes: Synthesis and
Bashir MA; Javaid K; Shaikh M; Choudhary MI; Siddiqui H
Med Chem; 2020; 16(8):1124-1135. PubMed ID: 32003674
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li X; Li J
Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors.
Wang G; Wang J; He D; Li X; Li J; Peng Z
Bioorg Med Chem Lett; 2016 Jun; 26(12):2806-2809. PubMed ID: 27177827
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors.
Wang G; He D; Li X; Li J; Peng Z
Bioorg Chem; 2016 Apr; 65():167-74. PubMed ID: 26964016
[TBL] [Abstract][Full Text] [Related]
14. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives.
Wang G; Chen M; Qiu J; Xie Z; Cao A
Bioorg Med Chem Lett; 2018 Jan; 28(2):113-116. PubMed ID: 29208524
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro biological activities and in silico study of dihydropyrimidines derivatives.
Barakat A; Islam MS; Al-Majid AM; Ghabbour HA; Fun HK; Javed K; Imad R; Yousuf S; Choudhary MI; Wadood A
Bioorg Med Chem; 2015 Oct; 23(20):6740-8. PubMed ID: 26381063
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, and In Vitro and In Silico α-Glucosidase Inhibitory Studies of 5-Chloro-2-Aryl Benzo[d]thiazoles.
Shah S; Arshia ; Javaid K; Zafar H; Mohammed Khan K; Khalil R; Ul-Haq Z; Perveen S; Iqbal Choudhary M
Bioorg Chem; 2018 Aug; 78():269-279. PubMed ID: 29614438
[TBL] [Abstract][Full Text] [Related]
18. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
[TBL] [Abstract][Full Text] [Related]
19. Study on the synthesis and biological activities of α-substituted arylacetates derivatives.
Liu J; Chen C; Wu F; Tang J
Bioorg Med Chem Lett; 2016 Apr; 26(7):1715-9. PubMed ID: 26920798
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li J; Li X
Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]